Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$Adma生物制品(ADMA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001140361-22-029116 Act: 34 Size: 8 MB 网页链接
$Adma生物制品(ADMA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001140361-22-029079 Act: 34 Size: 413 KB 网页链接
$Adma生物制品(ADMA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001140361-22-026720 Act: 33 Size: 146 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026722 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026723 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026724 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026725 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026726 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026727 Act: 33 Size: 94 KB 网页链接
$Adma生物制品(ADMA)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001140361-22-026728 Act: 33 Size: 94 KB 网页链接